Back to Trades
Henderson Jane
InsiderCIK 0001422304
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 14
- Buy transactions
- 0
- Sell transactions
- 18
- Companies
- 4
- Active
- 2025–2026
Across 14 filings between 2025–2026, Henderson Jane has disclosed $25.2M in transactions — spread across 4 companies. Their disclosed trades are heavily weighted toward selling — $0 in buys and $1.7M in sells. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
14 loaded
| Oct 26 | LYCA Lycia Therapeutics, Inc. | Henderson Jane | Insider | Award | $573.4K |
| Oct 22 | LYCA Lycia Therapeutics, Inc. | Henderson Jane | Insider | Other | $0 |
| Sep 3 | APGE Apogee Therapeutics, Inc. | Henderson Jane | Insider | Disposed | $16.5M |
| Jul 24 | APGE Apogee Therapeutics, Inc. | Henderson Jane | Chief Financial Officer | Gift | $0 |
| May 4 | APGE Apogee Therapeutics, Inc. | Henderson Jane | Chief Financial Officer | Sell | $164.1K |
| Apr 17 | APGE Apogee Therapeutics, Inc. | Henderson Jane | Chief Financial Officer | Sell | $180.0K |
| Mar 4 | APGE Apogee Therapeutics, Inc. | Henderson Jane | Chief Financial Officer | Sell | $140.4K |
| Feb 4 | APGE Apogee Therapeutics, Inc. | Henderson Jane | Chief Financial Officer | Sell | $131.6K |
| Jan 6 | APGE Apogee Therapeutics, Inc. | Henderson Jane | Chief Financial Officer | Sell | $609.1K |
| Dec 23 | APGE Apogee Therapeutics, Inc. | Henderson Jane | Chief Financial Officer | Sell | $120.0K |
| Nov 28 | APGE Apogee Therapeutics, Inc. | Henderson Jane | Chief Financial Officer | Sell | $105.0K |
| Nov 13 | APGE Apogee Therapeutics, Inc. | Henderson Jane | Chief Financial Officer | Sell | $60.0K |
| Aug 19 | CRGX CARGO Therapeutics, Inc. | Henderson Jane | Insider | Disposed | $108.8K |
| Aug 12 | AKRO Akero Therapeutics, Inc. | Henderson Jane | Insider | Sell | $142.4K |
14 filings